Search Within

Ross Levine

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (386)
  2. Meeting Abstract (343)
  3. Editorial (14)
  4. Review (13)
  5. Research Letter (10)
  6. Book Section (3)
  7. Conference Paper (2)
  8. Guidelines (2)
  9. Book Whole (1)
Groups
  1. Adult Leukemia (774)
  2. Center for Hematologic Malignancies (774)
  3. Department of Medicine (774)
  4. Executive Committee, Center for Hematologic Malignancies (774)
  5. GSK Faculty (774)
  6. Hematologic Malignancies, Division of (774)

More Groups

People
  1. Omar Abdel-Wahab (166)
  2. Martin Tallman (131)
  3. Raajit Rampal (87)
  4. Eytan Stein (69)
  5. Maria Arcila (60)
  6. Jay Patel (52)

More People

Years
  1. 2025 (5)
  2. 2024 (32)
  3. 2023 (46)
  4. 2022 (41)
  5. 2021 (44)
  6. 2020 (58)

More Years

Publications
  1. Blood (289)
  2. Leukemia (34)
  3. Cancer Research (27)
  4. Haematologica (24)
  5. Blood Advances (21)
  6. Cancer Cell (21)

More Publications

Publishers
  1. American Society of Hematology (312)
  2. Nature Publishing Group (107)
  3. American Association for Cancer Research (67)
  4. Cell Press (47)
  5. Ferrata Storti Foundation (24)
  6. American Society of Clinical Oncology (22)

More Publishers

Results (774)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cooperative epigenetic remodeling by TET2 loss and NRAS mutation drives myeloid transformation and MEK inhibitor sensitivity
    Meeting Abstract

    Kunimoto, H.; Meydan, C.; Nazir, A.; Shank, K.; Maher, R.; Rapaport, F.; Pronier, E.; Melnick, A.; Levine, R. L.; Shih, A. H.
    Blood (2016)

    Fulltext@MSK | Save
  • JAK1 as a convergent regulator of hematopoietic stem cell function and stress hematopoiesis
    Meeting Abstract

    Kleppe, M.; Spitzer, M. H.; Li, S.; Dong, L.; Papalexi, E.; Hill, C.; De Groote, S.; Keller, M.; Koppikar, P.; Rapaport, F.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Multicolor flow cytometry and multi-gene next generation sequencing are complimentary and highly predictive for relapse in acute myeloid leukemia following allogeneic hematopoietic stem cell transplant
    Meeting Abstract

    Getta, B. M.; Devlin, S.; Maloy, M. A.; Mohanty, A.; Arcila, M.; Tallman, M. S.; Levine, R. L.; Giralt, S. A.; Roshal, M.
    Blood (2016)

    Fulltext@MSK | Save
  • Importance of achieving complete remission (CR) after intensive therapy for acute myeloid leukemia (AML) in older adults age >= 60 years: Analysis of risk factors for early mortality and re-induction, and impact of quality of response on overall survival (OS) in the ECOG-ACRIN E2906 randomized trial
    Meeting Abstract

    Foran, J. M.; Sun, Z.; Claxton, D. F.; Lazarus, H. M.; Thomas, M. L.; Melnick, A.; Levine, R. L.; Paietta, E.; Arber, D. A.; Zhang, Y.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Cooperative gene repression by DNA methylation and LSD1-mediated enhancer inactivation in acute myeloid leukemia
    Meeting Abstract

    Duy, C.; Teater, M.; Garrett-Bakelman, F. E.; Lee, T. C.; Meydan, C.; Glass, J. L.; Li, M.; Mohammad, H.; Smitheman, K.; Shih, A. H.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Mutational analysis of clonal hematopoiesis in solid tumor patients illustrates the critical role of systemic anti-cancer therapies in the evolution of somatic leukemia disease alleles
    Meeting Abstract

    Coombs, C. C.; Zehir, A.; Devlin, S.; Kishtagari, A.; Hyman, D. M.; Solit, D.; Robson, M.; Baselga, J.; Arcila, M.; Tallman, M. S.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Hypermethylation of GADD45A defines a methylation profile distinct to mutant IDH1/2, and correlates with more aggressive AML
    Meeting Abstract

    Samaraweera, S. E.; Garrett-Bakelman, F. E.; Neelamraju, Y.; Perugini, M.; Casolari, D. A.; Iarossi, D.; Bray, S. C.; Sheridan, C.; Lee, T. C.; Tiong, I. S.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Impact of genomic alterations on outcomes in myelofibrosis patients undergoing allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Rampal, R. K.; Tamari, R.; Zhang, N.; McNamara, C. J.; Rapaport, F.; Litvin, R.; Maloy, M. A.; Castro-Malaspina, H.; Giralt, S.; Weinberg, R. S.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • TP53 mutations in AML predict adverse outcome in patients undergoing allogeneic hematopoietic stem cell transplant
    Meeting Abstract

    Getta, B. M.; Ghosh, A.; Coombs, C. C.; Devlin, S.; Arcila, M.; Mohanty, A.; Levine, R. L.; Tallman, M. S.; Jakubowski, A. A.; Giralt, S. A.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Clinical relevant alterations identified by comprehensive genomic profiling can potentially improve therapeutic option and change prognosis in hematologic malignancies
    Meeting Abstract

    He, J.; Patel, M.; Phillip, I.; Bailey, M.; Berman, E.; Park, J. H.; Shukla, N. N.; Chung, S. S.; Castro-Malaspina, H.; Douer, D.; more...
    Blood (2016)

    Fulltext@MSK | Save